Skip to content

Ibogaine for addiction: all studies

Page 6 of 10: studies 51 to 60 of 93, newest first. Back to the ibogaine for addiction overview

Research

Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.

Journal of Psychoactive Drugs 2018 Benjamin Malcolm, Martin Polanco, Joseph P Barsuglia 64 citations

Opioid use disorder (OUD) is currently an epidemic in the United States (US) and ibogaine is reported to have the ability to interrupt opioid addiction by simultaneously mitigating withdrawal and craving symptoms. This study examined opioid withdrawal and drug craving scores in 50 participants with OUD undergoing a week-long detoxification treatment protocol with ibogaine. The Addiction...

DOI: 10.1080/02791072.2018.1447175 (opens in new tab) Full text (opens in new tab) Opiate Ibogaine treatment ibogaine Therapy Medication +8

Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes.

Frontiers in Pharmacology 2018 Deborah C. Mash, Linda Duque, Bryan Page et al. 109 citations

Ibogaine may be effective for transitioning opioid and cocaine dependent individuals to sobriety. American and European self-help groups provided public testimonials that ibogaine alleviated drug craving and opioid withdrawal symptoms after only a single dose administration. Preclinical studies in animal models of addiction have provided proof-of-concept evidence in support of these claims....

DOI: 10.3389/fphar.2018.00529 (opens in new tab) Full text (opens in new tab) Noribogaine Detoxification Opioid dependence Ibogaine therapy: ibogaine +4

A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder.

Progress in Brain Research 2018 Joseph P Barsuglia, Martin Polanco, Robert Palmer et al. 37 citations

Ibogaine is a plant-derived alkaloid and dissociative psychedelic that demonstrates anti-addictive properties with several substances of abuse, including alcohol. 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic known to occasion potent mystical-type experiences and also demonstrates anti-addictive properties. The potential therapeutic effects of both compounds...

A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment

Journal of Psychedelic Studies August 29, 2017 Eduardo Ekman Schenberg, Maria Angélica de Castro Comis, João Felipe Morel Alexandre et al. 39 citations

Objective This report documents the phenomenology of the subjective experiences of 22 patients with substance-related disorders who were involved in a treatment combining cognitive–behavioral therapy and hospital sessions with ibogaine in Brazil. Methods Participants underwent a one-to-one semi-structured interview exploring the subjective effects of ibogaine. We employed interpretative...

Treating drug dependence with the aid of ibogaine: A qualitative study

Journal of Psychedelic Studies April 1, 2017 Eduardo Ekman Schenberg, Maria Angélica de Castro Comis, João Felipe Morel Alexandre et al. 29 citations

Substance use disorders are important contributors to the global burden of disease, but current treatments are not associated with high rates of recovery. The lack of approved and effective treatments is acutely problematic for psychostimulants like cocaine and crack cocaine. One promising alternative in the treatment of drug dependence in general and psychostimulants in particular is the use...

The antiaddictive effects of ibogaine: A systematic literature review of human studies

Journal of Psychedelic Studies April 1, 2017 Rafael G. Dos Santos, José Carlos Bouso, Jaime E. C. Hallak 36 citations

Ibogaine is a naturally occurring hallucinogenic alkaloid with a therapeutic potential for reducing drug craving and withdrawal. To the best of our knowledge, no systematic review was previously performed assessing these effects. Thus, we conducted a systematic literature review of human studies assessing the antiaddictive effects of ibogaine. Papers published up to July 2, 2016 were included...

DOI: 10.1556/2054.01.2016.001 (opens in new tab) Addiction Opiate Hallucinogen Pharmacology +5

Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Cardiovascular toxicology April 1, 2017 Lena Rubi, Daniel Eckert, Stefan Boehm et al. 18 citations

Ibogaine is a plant alkaloid used as anti-addiction drug in dozens of alternative medicine clinics worldwide. Recently, alarming reports of life-threatening cardiac arrhythmias and cases of sudden death associated with the ingestion of ibogaine have accumulated. Using whole-cell patch clamp recordings, we assessed the effects of ibogaine and its main metabolite noribogaine on action potentials...

DOI: 10.1007/s12012-016-9366-y (opens in new tab) Full text (opens in new tab) Noribogaine Action potential repolarization Anti-addiction drug ibogaine Cardiac arrhythmias +6

Ibogaine for treating drug dependence. What is a safe dose?

Drug and Alcohol Dependence September 1, 2016 Leo J. Schep, Robin J Slaughter, S Galea et al. 30 citations

The indole alkaloid ibogaine, present in the root bark of the West African rain forest shrub Tabernanthe iboga, has been adopted in the West as a treatment for drug dependence. Treatment of patients requires large doses of the alkaloid to cause hallucinations, an alleged integral part of the patient's treatment regime. However, case reports and case series continue to describe evidences of...

DOI: 10.1016/j.drugalcdep.2016.07.005 (opens in new tab) Full text (opens in new tab) Drug dependence Qt prolongation Ibogaine treatment ibogaine Current ibogaine doses +6

Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents.

Journal of psychopharmacology (Oxford, England) July 1, 2016 Deborah C. Mash, Barbara Ameer, Delphine Prou et al. 29 citations

This study investigated the effects of noribogaine, the principal metabolite of the drug ibogaine, on substance-related disorders. In the first experiment, mice chronically treated with morphine were subjected to naloxone-precipitated withdrawal two hours after oral administration of noribogaine. Oral noribogaine dose dependently decreased the global opiate withdrawal score by up to 88% of...

DOI: 10.1177/0269881116641331 (opens in new tab) Full text (opens in new tab) Cns drugs Blood–brain barrier Conditioned place preference Drug brain penetration +5

Ibogaine and addiction in the animal model, a systematic review and meta-analysis.

Translational Psychiatry May 31, 2016 Maarten Belgers, M Leenaars, Judith R. Homberg et al. 64 citations

Ibogaine is a naturally occurring substance which has been increasingly used in the lay-scene to reduce craving and relapse in patients with substance use disorders (SUDs). Although human clinical trials on the safety and efficacy of ibogaine are lacking, animal studies do support the efficacy of ibogaine. In this systematic review and meta-analysis (MA), we summarise these animal findings,...

DOI: 10.1038/tp.2016.71 (opens in new tab) Full text (opens in new tab) Ibogaine Addiction treatment Drug self-administration reduction Curbing addictive behaviors +11